Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Bashir Plus Endovascular Catheter

K-Number: K193071 · 2019-12-17

Decision Date2019-12-17
Product CodeQEY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Bashir Plus Endovascular Catheter is a medical device manufactured by Thrombolex, Inc.. It received FDA 510(k) clearance on 2019-12-17 under approval number K193071. The device is classified under product code QEY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Bashir Plus Endovascular Catheter?

Bashir Plus Endovascular Catheter is a medical device that received FDA 510(k) clearance on 2019-12-17. It is manufactured by Thrombolex, Inc.. The 510(k) number is K193071.

When was Bashir Plus Endovascular Catheter approved by the FDA?

Bashir Plus Endovascular Catheter received FDA 510(k) clearance on 2019-12-17, under approval number K193071.

What company makes Bashir Plus Endovascular Catheter?

Bashir Plus Endovascular Catheter is manufactured by Thrombolex, Inc..

What is the FDA product code for Bashir Plus Endovascular Catheter?

The FDA product code for Bashir Plus Endovascular Catheter is QEY.

Related Clinical Trials

Other Devices by Thrombolex, Inc.

Related Devices (Code: QEY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.